PADI4 and cancer: Therefore, the development of PAD4 inhibitors with high efficiency, high selectivity and improved bioavailability remains critical to elucidate the role played by PAD4 under physiological conditions and during disease progression to generate a potential therapeutic option for PAD4-dependent diseases, especially cancer and associated thrombosis [309].